India Adds Compulsory Drug Licenses [PDF]
Abstract The Indian government granted compulsory licenses for 3 cancer drugs, including breast cancer agents Herceptin (trastuzumab; Genentech) and Ixempra (ixabepilone; Bristol-Myers Squibb) and leukemia therapeutic Sprycel (dasatinib; Bristol-Myers Squibb).
openaire +3 more sources
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis.
BackgroundIt is now a decade since the World Trade Organization (WTO) adopted the "Declaration on the TRIPS Agreement and Public Health" at its 4th Ministerial Conference in Doha. Many anticipated that these actions would lead nations to claim compulsory
Reed Beall, Randall Kuhn
doaj +3 more sources
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications? [PDF]
Bognar CLFB, Bychkovsky BL, Lopes GL.
europepmc +2 more sources
“Trade-Related Aspects” and “Public Interest” in the TRIPS Agreement (WTO)
The article appears to be attempt to decipher such notions as “trade – related” aspects of IPR and “public interest” in The TRIPS Agreement. It is particularly striking that this article reveals that TRIPS negotiators, representing both developed and ...
V. V. Pirogova
doaj +1 more source
Lessons Learned from Philip Morris V. Uruguay Regarding the Approaches Taken in the Investment Protection Treaties of Iran towards Expropriation of Intellectual Property [PDF]
IntroductionIn the field of intellectual property rights, host states’ policies, and accordingly, the approach of the relevant treaty towards expropriation and intellectual property rights play a key role when separating expropriation from regulatory ...
Soroosh Falahati, Mirghasem Jafarzade
doaj +1 more source
The WTO and the Covid‐19 “Vaccine Apartheid”: Big Pharma and the Minefield of Patents
Unequal access to vaccines for the Covid-19 pandemic, also referred to as “vaccine apartheid,” has marginalized low-income countries again. In October 2020, India and South Africa proposed a temporary waiver from certain provisions of the TRIPS Agreement
Stéphane Paquin +1 more
doaj +1 more source
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health? [PDF]
BACKGROUND: The heads of the Global Fund and the GAVI Alliance have recently promoted the idea of an international tiered pricing framework for medicines, despite objections from civil society groups who fear that this would reduce the leeway for ...
Forman, Lisa +3 more
core +2 more sources
Compulsory licensing and access to drugs [PDF]
Compulsory licensing allows the use of a patented invention without the owner's consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it can be detrimental to innovation. We model the interaction between a company in the North that holds the patent for a certain drug and a government in ...
Stavropoulou, C, VALLETTI, TOMMASO MARIA
openaire +4 more sources
The Doha Round’s Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions [PDF]
This entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the international intellectual property system. The harmonization of basic intellectual property standards has operated to protect investment in innovation ...
Abbott, Frederick M. +1 more
core +2 more sources
[Un]happy Together: Why the Supremacy Clause Preempts State Law Digital Performance Rights in Radio-Like Streaming of Pre-1972 Sound Recordings [PDF]
Lovers of the music of Frank Sinatra, Elvis Presley, Etta James, and hundreds of other recording artists whose records were made before February 15, 1972, may soon have a hard time hearing these great artists on any satellite or Internet radio service ...
Ross, Julie L.
core +3 more sources

